Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times of Connecticut.
Press releases published on April 8, 2025
Netcoins Canada Hires Prentis Beck-Sayers to Bolster Sales and Trading Team; Approval of BIGG Omnibus Equity Plan
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group …
SEALSQ Appoints COO to Spearhead Its North American Operations and Accelerate Growth in Semiconductor and Quantum-Resistant Security Technologies
GlobeNewswire
·
April 8, 2025
Geneva, Switzerland, April 08, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, announced today …
Shareholder-Approved Merger with Verde Bioresins, Inc. Progressing Towards Close
GlobeNewswire
·
April 8, 2025
MESA, Ariz., April 08, 2025 (GLOBE NEWSWIRE) -- Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, today announced …
3D Systems’ Solution Enables World’s First Facial Implant Manufacturing at Point-of-Care
GlobeNewswire
·
April 8, 2025
First 3D-printed PEEK facial implant manufactured at the point-of-care using 3D Systems’ EXT 220 MED Point-of-care collaboration between surgeons, engineers, and technology enables tailored solutions to address complex patient needs 3D Systems’ solutions …
AvidXchange Announces Timing of Its First Quarter 2025 Financial Results Conference Call and Webcast
GlobeNewswire
·
April 8, 2025
CHARLOTTE, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) automation software and payment solutions for middle market businesses and their suppliers, today announced that its …
Intuitive Machines Selects SpaceX to Launch its Fourth Lunar Lander Mission and Lunar Data Relay Satellites
GlobeNewswire
·
April 8, 2025
HOUSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW) (“Intuitive Machines”) (“Company”), a leading space exploration, infrastructure, and services company, has recently selected SpaceX’s Falcon 9 rocket to launch its …
3D Bioprinting Market Worth US$2.4 billion | MarketsandMarkets™.
GlobeNewswire
·
April 8, 2025
Delray Beach, FL, April 08, 2025 (GLOBE NEWSWIRE) -- 3D Bioprinting Market, valued at US$1.2 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$1.3 billion in 2024 and an impressive US$2.4 billion by 2029 according to a published …
NR7 Miner launches Smart Cloud Computing 2.0, leading the world to open a new era of free cloud mining
GlobeNewswire
·
April 8, 2025
Washington D.C., USA, April 08, 2025 (GLOBE NEWSWIRE) -- In today's turbulent global cryptocurrency market, NR7 Miner, an industry-leading cloud mining service provider, officially launched the "Smart Cloud Computing 2.0" service today, marking the …
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
GlobeNewswire
·
April 8, 2025
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development …
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
GlobeNewswire
·
April 8, 2025
CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
GlobeNewswire
·
April 8, 2025
MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, …
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 8, 2025
NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentation PRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy …
Melissa Celebrates 40th Anniversary as the Address Expert
GlobeNewswire
·
April 8, 2025
RANCHO SANTA MARGARITA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Celebrating an industry milestone, Melissa today announced its 40th anniversary as the Address Expert. The company is a global leader in data quality and address management solutions, and …
Regula Wins Gold in the Globee Awards for Cybersecurity for Its Complete Identity Verification Solution
GlobeNewswire
·
April 8, 2025
RESTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of forensic devices and identity verification (IDV) solutions, has received Gold in the 2025 Globee Awards for Cybersecurity. This marks Regula’s second consecutive year of winning …
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
GlobeNewswire
·
April 8, 2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company has enrolled 50% of the patients in its ASCEND clinical trial for VIA Disc NPTM. The ASCEND study is a …
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
GlobeNewswire
·
April 8, 2025
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data …
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
GlobeNewswire
·
April 8, 2025
SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
TransGlobal Assets Inc. (OTC: TMSH) Set to Transform Fintech and Dating with AI-Powered Platforms: Intelligent Debt Solutions and DateGuard
GlobeNewswire
·
April 8, 2025
AI-First Debt Solutions That Prioritize Human Wellness: Intelligent Debt Solutions leverages real-time behavioral analytics and ethical AI to offer highly personalized financial recovery pathways for individuals while boosting efficiency and empathy in …
Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter
GlobeNewswire
·
April 8, 2025
Strategic expansion into longevity market creates near-term commercial opportunity alongside continued clinical advancement of JOTROL™ JOTROL™ development programs remain tariff-exempt; consumer longevity line on track with negligible cost exposure Jupiter …
NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
GlobeNewswire
·
April 8, 2025
Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy1 Long-term seizure reduction with a median reduction of 82% at 3 years. Seizure freedom with 42% of patients …